Overview

Baricitinib in Idiopathic Granulomatous Mastitis

Status:
Recruiting

Trial end date:
2025-10-31

Target enrollment:

Participant gender:

Summary

This study will explore the mechanism of targeted drug in treatment of idiopathic granulomatous mastitis, and clarify the clinical classification and corresponding markers.

Phase:

Phase 2

Details

Lead Sponsor:

First Affiliated Hospital of Zhejiang University